COMPANY

Gate Bioscience

HQ: Brisbane, CA source · gatebio.com ↗ · West Coast

Location: Brisbane, CA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Raises and deals from press releases

Deal Deal · up to $870M total · announced Oct 5, 2026 Company release ↗
Source quote
- Oct 5, 2026 · Company release ↗
  “The total potential value of the agreement could exceed $870 million, contingent on the achievement of milestones.”
Raise Series B · $65M · announced Nov 13, 2025 Company release ↗
Source quote
- Nov 13, 2025 · Company release ↗
  “Gate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic”
Deal Lilly deal · amount not disclosed · announced Jul 24, 2025 Company release ↗
Source quote
- Jul 24, 2025 · Company release ↗
  “Gate Bioscience, a biotechnology company developing molecular gates, a new class of small molecule drugs to eliminate disease-causing proteins at their source, today announced a collaboration and license agreement with Eli Lilly and Company (“Lilly”) to discover”

Raises announced in these releases: $65M disclosed.

From the company’s own releases; this list is partial. All raises and deals

Nov 13, 2025 Raise Private equity round — Series B: $65M (total, as published), announced Nov 13, 2025. Source: company release on GlobeNewswire. source ↗
Nov 13, 2025 Raise Series B · $65M source ↗

Raised: $65.0M. Last 2 years.

Nov 13, 2025 Private equity round — Series B: $65M (total, as published), announced Nov 13, 2025. Source: company release on GlobeNewswire. source ↗

Form D raises come from the company’s own SEC filing (last 2 years).

InvestorListed in the portfolio of ARCH Venture Partners (captured Oct 12, 2026). portfolio page ↗